Published September 23, 2023 | Version v1

Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition

  • 1. Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland
  • 2. Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, B15 2TT, UK
  • 3. Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, OX3 7LE UK
  • 4. Department for Biosciences, Nottingham Trent University, Nottingham, NG11 8NS UK

Description

Data-Sets of, “Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition”

The Dataset (Derived from https://doi.org/10.1111/bph.16251) contains the original figures and tables as PNG-format (10.1111_bph.16251_Figure 1-4.PNG; 10.1111_bph.16251_Table1-2.PNG and supplemental information 10.1111_bph.16251_FigS1-S2.PNG; 10.1111_bph.16251_TableS1-S6.PNG), as well as the graphical abstract.PNG

Corresponding raw data and subsequent data analysis obtained from LC-MS/MS analysis and reused data on THF, THE and allo-THE and clinical parameters  as well as the statistical evaluation of obtained data are provided as raw-files and corresponding meta data-files (FAIR-Principle).

Fig 2:

Two files in CSV format (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_4_3.csv and 310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_28_1.csv). Detailed description of the LC-MS/MS method is provided as pdf-Format (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_4_M_2.pdf). All further experiment related information provided as one meta-data-file (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_4_3_M .txt) in txt format and two files containing further related information (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_M_A1-2 .pdf) PDF format.

Fig3:

Two files in CSV format (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_4_4.csv; 310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_28_2.csv). One meta data file as pdf-format with detailed LC-MS/MS method description 310030-(214978_10.1111_bph.16251_CGC_Human_Biomarker_4_M_2.pdf). All further related information are provided as one meta-data-file (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_4_4_M .txt) in txt format. Cohort B related information is provided as three files in pdf- format (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_M_B1-3).

Fig 4:

Six files in CSV format (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_4_3-5 .csv, 310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_26_1.csv and 214978_10.1111_bph.16251_CGC_Human_Biomarker_28_1-2.csv). Two meta data file as pdf-format with detailed LC-MS/MS method descriptions (214978_10.1111_bph.16251_CGC_Human_Biomarker_4_M_2-3 .pdf ). All further related information are provided as one meta-data-file (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_4_3-5_M.txt) in txt format. Cohort related information is provided as five files in pdf- format (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_M_A1-2 and B1-3.pdf) Statistical analysis is provided as R-File (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_26_M_1_1.R).

Tab1:

One file in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_1 .csv). One meta file as pdf-format with detailed LC-MS/MS method description (214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_M_1.pdf ). All further related information are provided as one meta-data-file (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_1_M.txt) in txt format. Cohort A related information is provided as two files in pdf- format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_A1-2).

Tab2:

One file in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_2.csv). One meta data file as pdf-format with detailed LC-MS/MS method description (214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_M_1.pdf ). All further related information are provided as one meta-data-file (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_2_M.txt) in txt format. Cohort B related information is provided as three files in pdf- format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_B1-3).

Fig S1:

Four files in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_3-4.csv and 214978_10.1111_BPH.16251_CGC_Human_Biomarker_28_1-2.csv). One meta data file as pdf-format with detailed LC-MS/MS method description (214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_M_2.pdf ). All further related information are provided as one meta-data-file (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_3-4_M.txt) in txt format. Cohort A and B related information is provided as five files in pdf- format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_A1-2 and-B1-3).

Fig S2:

Five files in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_3-4.csv and 310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_26_2.csv, 310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_28_1-2.csv) and one file as R-File (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_26_2_M1.R). One meta data file as pdf-format provides detailed LC-MS/MS method description (214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_M_2.pdf). All further related information are provided as one meta-data-file (310030 214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_26_2_M.txt) in txt format. Cohort A and B related information is provided as five files in pdf- format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_A1-2 and-B1-3).

Tab S1:

One file in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_28_3.csv). All further related information are provided as one meta-data-file (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_28_3_M.txt) in txt format. Cohort A related information is provided as two files in pdf- format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_A1-2). 

TabS2:

One file in CSV format (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_28_4.csv). All further related information are provided as one meta-data-file (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_28_4_M.txt) in txt format. Cohort B related information is provided as three files in pdf- format (310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_M_B1-3).

TabS3:

One file in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_3.csv). Detailed description of the LC-MS/MS method is provided as pdf-Formate (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_M_2.pdf) All further experiment related information provided as one meta-data-file (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_26_3_M.txt) in txt format and  two files containing further related information (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_A1-2 .pdf) PDF format.

Tab S4:

Three file in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_5.csv, 310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_26_1-2.csv). Detailed description of the LC-MS/MS methods is provided two files pdf-Format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_M_2-3.pdf) All further experiment related information provided as one meta-data-file (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_26_4_M.txt) in txt format. Cohort related information is provided as two files in pdf- format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_A1-2. Statistical analysis is provided as R-File (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_26_M_1.R).

TabS5:

One files in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_4.csv One meta data file as pdf-format with detailed LC-MS/MS method description (214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_M_2.pdf ). All further related information are provided as one meta-data-file (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_26_5_M.txt) in txt format. Cohort B related information is provided as three files in pdf- format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_B1-3).

TabS6:

Four files in CSV format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_4-5.csv 310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_28_4.csv; 310030-214978_10.1111_bph.16251_CGC_Human_Biomarker_26_1.csv). One meta data file as pdf-format with detailed LC-MS/MS method description (214978_10.1111_BPH.16251_CGC_Human_Biomarker_4_M_2-3.pdf ). All further related information are provided as one meta-data-file (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_26_6_M.txt) in txt format. Cohort B related information is provided as three files in pdf- format (310030-214978_10.1111_BPH.16251_CGC_Human_Biomarker_M_B1-3).

Notes

Conclusion and Implications:11β-HSD1inhibition does not cause major alterations in bile acid homeostasis.The GUDCA/G7oxoLCA ratio represents the first blood biomarker of pharmacological 11β-HSD1inhibition and may replace or complement the urinary (5αTHF+THF)/THE ratio biomarker.

Files

10.1111_bph.16251_Figure1.PNG

Files (10.5 MB)

Name Size Download all
md5:404e419bd5d9f1523df7514d330940c6
121.6 kB Preview Download
md5:c09b450c4fa44d9b1e7fc53c27c7f20e
150.8 kB Preview Download
md5:f87d07446cd648b2157eee5d4c6f4ffa
163.6 kB Preview Download
md5:068b25e0d68a62f06c348d6dcafbab8c
117.1 kB Preview Download
md5:12a3c959adc8725f869828a57855ce9f
161.9 kB Preview Download
md5:44afa4f8dd78235735d512ac9ddcede6
146.6 kB Preview Download
md5:e0159dca9e7440912c6cb3850c987913
91.7 kB Preview Download
md5:3ce43053da7760182d0c085a55818b87
83.1 kB Preview Download
md5:16400e35ac97609c610540e9922d97b9
84.2 kB Preview Download
md5:61965593b0992936604b513354238b8f
85.2 kB Preview Download
md5:81f4245de8fa4c485c6dca4ae0941202
40.8 kB Preview Download
md5:bec7ad2bb87cacc35829211b2bf94b78
65.7 kB Preview Download
md5:a67576ca28dffa857b4d8b65379aa037
42.5 kB Preview Download
md5:573586ae94a4bc90c4edab858983c5eb
75.5 kB Preview Download
md5:37a12302cfdb11a51e4c7b74a298f101
5.3 kB Preview Download
md5:be8cdd635df085e67eef53f21030c26d
21.2 kB Download
md5:e6af5f9a9fef839f66409f371569a326
11.0 kB Preview Download
md5:cc40ad0c39e243eb2ac3e0439037a3d8
8.8 kB Preview Download
md5:2c4d5ad52d1156743013341d621f4806
5.0 kB Download
md5:42971a601dbb5ababf89228f14791c2a
6.7 kB Preview Download
md5:0fb450dd3a2d833b3ae6e56147d2c10b
7.2 kB Preview Download
md5:7d7c015b7fe9265fbdee17dd5c1ee1a0
7.0 kB Preview Download
md5:6f2b1d4e87bac1b291a25add7dcb3207
7.3 kB Preview Download
md5:81767b7b0865951594e0efdf77325b59
7.7 kB Preview Download
md5:1ab843a3c3bcbcc87d1d397b16c05adb
8.0 kB Preview Download
md5:9c91b2e28e16fc258c1c28fd810a9ebc
5.2 kB Preview Download
md5:1797d6c6195d862dbaa67478fbea74f2
2.4 kB Preview Download
md5:d5ca5026f3e84597a342c943ec52327c
19.9 kB Preview Download
md5:10fedfb3026099de3bccd4950ea1e4d8
2.6 kB Preview Download
md5:31002093d441194a53d11033dc72f408
109.3 kB Preview Download
md5:f3d2005b04062c45436086e047ac5dc1
6.7 kB Preview Download
md5:8cad18ea31e9134aef124e6a55bb80d9
85.2 kB Preview Download
md5:b2c5c5a9b7b8282d8692690fa572e2be
7.0 kB Preview Download
md5:868dfe0208cb98c7625a2b650b8d21ba
8.5 kB Preview Download
md5:f725a550055514b9f1b2373054c161e2
9.0 kB Preview Download
md5:5edcba3b1741462e732f8bb0056ea086
34.2 kB Preview Download
md5:4a8357663071a69d6f74ca70e12c696c
7.0 kB Preview Download
md5:5edcba3b1741462e732f8bb0056ea086
34.2 kB Preview Download
md5:b30b7e982953a4b99f6d967495ded5ec
7.2 kB Preview Download
md5:9d05262e5ccaf09bb785759fd7dfa26e
5.8 kB Preview Download
md5:b57d32b67a42b57a3eb887047d82200c
463.5 kB Preview Download
md5:d2bdf13cdbf3c78f585823f86f34101c
439.5 kB Preview Download
md5:2eb5d65c2fdace1af568d1a34baa0f50
438.1 kB Preview Download
md5:c515b8c766b89a18f2966e7014679249
2.3 MB Preview Download
md5:287a80ab89ccef3e4aa7a10365bf53ee
352.2 kB Preview Download
md5:667b13bc12e4922a26b1ba7e9250d38d
3.9 MB Preview Download
md5:91b62c34ee8e5f88c1c0bd5f6a55bbb8
282.5 kB Preview Download
md5:47713dbaf0959a773d4e45b1f5b70bd9
232.8 kB Preview Download
md5:2398e3c2a7c27f5c64415ac087042fcb
162.9 kB Preview Download

Additional details

Related works

Is derived from
Journal article: 10.1111/bph.16251 (DOI)

Funding

Swiss National Science Foundation
Impact of the NADPH pool in the endoplasmic reticulum on metabolic and hormonal regulation 31003A_179400
Swiss National Science Foundation
Impact of the NADPH pool in the endoplasmic reticulum on metabolic and hormonal regulation 214978